Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 3 | 3 | 2 | 2 | 1 | 0 | 1 | 1 | 2 | 2 | 3 | 3 | |||||
Assets Current | |||||||||||||||||
Assets Current | 4 | 3 | 2 | 2 | 1 | 0 | 1 | 1 | 2 | 2 | 3 | 3 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deposits Assets Current | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Investment In Physical Commodities | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 4 | 4 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 4 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 11 | 11 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 9 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Loans Payable Current | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Liabilities Noncurrent | |||||||||||||||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 11 | 11 | 11 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 9 | |||||
Additional Paid In Capital | 13 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -7 | -7 | -8 | -8 | -8 | -9 | -8 | -7 | -7 | -6 | -6 | -5 | |||||
Retained Earnings Accumulated Deficit | -59 | -58 | -57 | -56 | -54 | -54 | -53 | -52 | -52 | -50 | -50 | -48 | |||||
Liabilities And Stockholders Equity | 4 | 4 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | 3 | 4 | |||||
Investment Owned At Cost | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Issued | - | - | - | - | 315 | 2,158 | - | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.29% | -21.43% | -35.71% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.00% | -11.11% | -11.11% | 0.00% | 12.50% | 12.50% | 0.00% | 0.00% | -11.11% | 36.36% | 18.18% | 0.00% |
| 2024 | 8.33% | 16.67% | -16.67% | -18.18% | -18.18% | -18.18% | 22.22% | 11.11% | 0.00% | 12.50% | 12.50% | 12.50% |
| 2023 | - | - | - | -25.00% | -25.00% | -25.00% | 0.00% | 33.33% | 33.33% | -10.00% | 10.00% | 50.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.33 | 0.28 | 0.18 | 0.16 | 0.08 | 0.05 | 0.08 | 0.13 | 0.17 | 0.23 | 0.29 | 0.35 | |||||
| Quick Ratio | 0.31 | 0.27 | 0.17 | 0.15 | 0.08 | 0.04 | 0.07 | 0.13 | 0.17 | 0.23 | 0.29 | 0.35 | |||||
| Working Capital | -7.33M | -7.67M | -8.58M | -8.54M | -9.19M | -9.37M | -8.87M | -8.10M | -7.61M | -6.90M | -6.31M | -5.57M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.63 | -1.53 | -1.32 | -1.30 | -1.19 | -1.15 | -1.18 | -1.28 | -1.32 | -1.44 | -1.57 | -1.73 | |||||
| Interest Coverage TTM | -6.27 | -6.25 | -5.91 | -5.99 | -4.28 | -5.94 | -5.81 | -4.69 | -4.81 | -4.19 | -5.40 | -15.91 | |||||
| Debt Ratio | 2.58 | 2.90 | 4.12 | 4.38 | 6.32 | 7.50 | 6.41 | 4.63 | 4.14 | 3.25 | 2.77 | 2.38 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.04 | 0.04 | 0.03 | 0.02 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | - | - | - | -11,301.04% | -5,846.74% | -3,260.94% | -1,944.92% | -2,386.65% | -2,549.67% | |||||
| Net Profit Margin TTM | - | - | - | - | - | - | -12,493.34% | -6,382.74% | -3,630.11% | -2,242.24% | -2,765.43% | -3,484.74% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | - | - | -100.00% | -100.00% | -100.00% | -100.00% | -75.17% | -20.29% | 308.29% | 3,003.68% | - | - | |||||
| Net Income Growth (1Y) | 58.92% | 13.60% | 6.60% | -4.76% | -34.53% | 17.51% | 12.18% | 46.00% | 36.90% | -11.64% | -21.14% | -34.67% | |||||
| EPS Growth (1Y) | 49.92% | 8.46% | 4.48% | -7.43% | -35.10% | 17.16% | 11.62% | 45.30% | 36.24% | -12.17% | -25.63% | -38.26% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -26.76 | -30.26 | -26.32 | -26.07 | -32.09 | -26.85 | -27.49 | -24.14 | -33.85 | -34.95 | -13.64 | -11.69 | |||||
| P/B TTM | -16.45 | -16.99 | -11.92 | -12.08 | -9.89 | -10.97 | -11.47 | -12.70 | -19.36 | -16.64 | -7.24 | -6.20 | |||||
| P/S TTM | - | - | - | - | - | - | 3,435.04 | 1,540.56 | 1,228.76 | 783.70 | 377.19 | 407.36 | |||||
| Market Cap | 111.03M | 120.00M | 95.35M | 96.14M | 83.80M | 93.73M | 93.45M | 93.45M | 134.99M | 103.84M | 41.32M | 31.00M | |||||
| Enterprise Value | 107.64M | 117.10M | 93.56M | 94.58M | 83.01M | 93.33M | 92.78M | 92.26M | 133.47M | 101.81M | 38.81M | 28.16M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -2.08M | -1.90M | -1.79M | -1.86M | -1.72M | -1.78M | -1.84M | -1.65M | -1.58M | -1.34M | -1.25M | -1.36M | |||||
| Net Debt | -3.39M | -2.89M | -1.79M | -1.57M | -785.46K | -397.00K | -673.26K | -1.19M | -1.52M | -2.03M | -2.52M | -2.84M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Kraig Biocraft Laboratories, Inc. (KBLB) — SEC Financial Statements & Analysis
Kraig Biocraft Laboratories, Inc. (KBLB) is a plastic material, synth resin/rubber, cellulos (no glass) company, incorporated in WY. Kraig Biocraft Laboratories, Inc. trades on OTC as: KBLB. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Kraig Biocraft Laboratories, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -1.63x, a Price-to-Sales (P/S) ratio of 3435.04x (TTM), a Price-to-Book (P/B) ratio of -16.45x (TTM), at a market cap of $111.03M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- -1.63x
- P/S TTM
- 3435.04x
- P/B TTM
- -16.45x
- Market Cap
- $111.03M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Kraig Biocraft Laboratories, Inc. in?
Kraig Biocraft Laboratories, Inc. (KBLB) operates in the Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) industry.
What is KBLB's market cap?
Kraig Biocraft Laboratories, Inc. (KBLB) has a market capitalization of $111.03M as of 2026-06-30.
What exchange does KBLB trade on?
Kraig Biocraft Laboratories, Inc. (KBLB) trades on the OTC.
Where is Kraig Biocraft Laboratories, Inc. incorporated?
Kraig Biocraft Laboratories, Inc. is incorporated in WY.